CHONGQING, CHINA - APRIL 20: In this photo illustration, the Bristol Myers Squibb logo is displayed on a smartphone screen, with the company's signature purple branding in the background, on April 20, ...
The drugmaker is testing its antipsychotic drug Cobenfy for the treatment of psychosis associated with Alzheimer’s disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback